XML 73 R33.htm IDEA: XBRL DOCUMENT v3.25.0.1

Revenue Recognition (Tables)

12 Months Ended

Dec. 31, 2024

Revenue Recognition [Abstract]

Schedule of Disaggregated Revenue

Segment Net Sales
MedSurg and Neurotechnology:			2024						2023						2022
Instruments			$	2,834					$	2,534					$	2,245
Endoscopy			3,389						3,068						2,759
Medical			3,852						3,459						3,031
Neurovascular			1,307						1,226						1,200
Neuro Cranial			2,136						1,876						1,658
			$	13,518					$	12,163					$	10,893
Orthopaedics:
Knees			$	2,447					$	2,273					$	1,997
Hips			1,704						1,544						1,413
Trauma and Extremities			3,507						3,147						2,807
Spinal Implants			707						713						733
Other			712						658						606
			$	9,077					$	8,335					$	7,556
Total			$	22,595					$	20,498					$	18,449

United States Net Sales
MedSurg and Neurotechnology:			2024						2023						2022
Instruments			$	2,267					$	2,016					$	1,776
Endoscopy			2,792						2,513						2,245
Medical			3,191						2,785						2,422
Neurovascular			506						483						446
Neuro Cranial			1,761						1,531						1,359
			$	10,517					$	9,328					$	8,248
Orthopaedics:
Knees			$	1,788					$	1,676					$	1,493
Hips			1,059						988						896
Trauma and Extremities			2,586						2,297						2,035
Spinal Implants			489						500						511
Other			504						468						455
			$	6,426					$	5,929					$	5,390
Total			$	16,943					$	15,257					$	13,638

International Net Sales
MedSurg and Neurotechnology:			2024						2023						2022
Instruments			$	567					$	518					$	469
Endoscopy			597						555						514
Medical			661						674						609
Neurovascular			801						743						754
Neuro Cranial			375						345						299
			$	3,001					$	2,835					$	2,645
Orthopaedics:
Knees			$	659					$	597					$	504
Hips			645						556						517
Trauma and Extremities			921						850						772
Spinal Implants			218						213						222
Other			208						190						151
			$	2,651					$	2,406					$	2,166
Total			$	5,652					$	5,241					$	4,811

Changes in Contract Liabilities

Changes in contract liabilities during the year were as follows:

			2024
Beginning contract liabilities			$	860
Revenue recognized from beginning of year contract liabilities			(553)
Net advance consideration received during the period			671
Ending contract liabilities			$	978

X

- Definition

Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-10

+ Details

Name:	us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueRecognitionAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration